Solid Compositions Comprising A Glp-1 Agonist And A Salt Of N-(8-(2-Hydroxybenzoyl)Amino)Caprylic Acid - EP3790575
The patent EP3790575 was granted to Novo Nordisk on Jul 30, 2025. The application was originally filed on May 6, 2019. The patent is currently recorded with a legal status of "Granted".
EP3790575
- Filing Date
- May 6, 2019
- Status
- Granted
- Grant Date
- Jul 30, 2025
- External Links
- Slate, Register, Google Patents
Patent Summary
Patent Family
Dossier Documents
The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.
Get instant alerts for new documents